The Pharmacology of LXR

E-ISSN： 1875-5607|5|8|729-740

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.5, Iss.8, 2005-08, pp. : 729-740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential

By Gong Haibiao Xie Wen

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 1, 2004-02 ,pp. : 49-54

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1312-1323

Bentham Science Publishers

Access to resources Recommend Favorite

LXR-Agonists Regulate ApoM Expression Differentially in Liver and Intestine

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. : 516-521

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of anhedonia

By Willner P.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 214-214

Elsevier

Access to resources Recommend Favorite

The pharmacology of methotrexate

By Barnhart K. Coutifaris C. Esposito M.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 409-417

Informa Healthcare

Access to resources Recommend Favorite